Latest Acute myeloid leukemia Stories
- AbbVie Presents for the First Time Results from the Venetoclax Phase 2 Program in Acute Myelogenous Leukemia NORTH CHICAGO, Ill., Dec.
SAN FRANCISCO, Dec.
TG02 demonstrates ability to mobilize difficult-to-kill leukemic stem cells and render them vulnerable to chemotherapy. San Diego, California (PRWEB) December
-Profile Supports Potential Role in Modulating Tumor Microenvironment in Blood-Related Cancers, Including AML, MDS, CMML and CLL- SEATTLE, Dec.
SAN DIEGO and PARSIPPANY, N.J., Dec.
SAN DIEGO AND TORONTO, Dec.
Interim Data from 33 Evaluable Patients to be Presented at ASH on Saturday SAN DIEGO, Dec. 2, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Live Webcast from San Francisco on December 8th SAN DIEGO, Dec. 1, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Company expects Induction Response Rate data in Second Quarter of 2015 EWING, N.J., Dec. 1, 2014 /PRNewswire/-- Celator Pharmaceuticals, Inc.
SEATTLE, Dec. 1, 2014 /PRNewswire/ -- CTI BioPharma Corp.
- A volcanic mudflow.